Trends in Haemophilus influenzae type b infections in adults in England and Wales: Surveillance study

BMJ

Volumn 329, Issue 7467, 2004, Pages 655-658

  Mcvernon, Jodie ^a   Trotter, Caroline L ^a   Slack, Mary P E ^b   Ramsay, Mary E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CROSS-SECTIONAL STUDY; EPIGLOTTITIS; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; MIDDLE AGED; PROSPECTIVE STUDY; UNITED KINGDOM; ANTIBODY BLOOD LEVEL; BACTERIUM ISOLATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH PROGRAM; HEALTH SURVEY; IMMUNIZATION; META ANALYSIS; PRIORITY JOURNAL; SEROPREVALENCE; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; ENGLAND; EPIGLOTTITIS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; WALES;

ANTIBODY;

EID: 4644253794     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7467.655     Document Type: Article

References (22)

1. Health Protection Agency. Quarterly communicable disease reports on the COVER programme for childhood immunisation. www.hpa.org.uk/infections/topics_az/vaccination/cover_cdr.htm (accessed 11 Aug 2004).
2. Trotter CL, Ramsay ME, Slack MPE. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health 2003; 6: 55–58.
3. Ramsay ME, McVernon J, Andrews N, Heath PT, Slack MPE. Estimating Hib vaccine efficacy in England and Wales using the screening method. J Infect Dis 2003; 188: 481–5.
4. Trotter CL, McVernon J, Andrews NJ, Burrage M, Ramsay ME. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet 2003; 361: 1523–4.
5. McVernon J, Andrews NJ, Slack MPE, Ramsay ME. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003; 361: 1521–3.
6. Sarangi J, Cartwright K, Stuart J, Brookes S, Morris R, Slack M. Invasive Haemophilus influenzae disease in adults. Epidemiol Infect 2000; 124: 441–7.
7. Osborne K, Gay N, Hesketh L, Morgan-Capner P, Miller E. Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol 2000; 29: 362–8.
8. Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990; 135: 121–8.
9. National Statistics Online. Birth statistics: births and patterns of family building England and Wales (FM1). www.statistics.gov.uk/StatBase/Product.asp?vlnk=5768&Pos=3&ColRank=1&Rank=144 (accessed 7 Jul 2004).
10. McVernon J, Howard AJ, Slack MPE, Ramsay ME. Long term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect 2004; 132: 765–7.
11. Slack MPE, Azzopardi HJ, Hargreaves RM, Ramsay ME. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines. Pediatr Infect Dis J 1998; 17: S204–S207.
12. Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 3130–6.
13. Boisvert PL. Familial epidemiology of Haemophilus influenzae, type b, infections. Am J Dis Child 1948; 427–8.
14. Michaels RH, Norden CW. Pharyngeal colonization with Haemophilus influenzae type b: a longitudinal study of families with a child with meningitis or epiglottitis due to H influenzae type b. J Infect Dis 1977; 136: 222–8.
15. Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995; 171: 93–98.
16. Rijkers GT, Vermeer-de Bondt PE, Spanjaard L, Breukels MA, Sanders EAM. Return of Haemophilus influenzae type b infections. Lancet 2003; 361: 1563.
17. European Union Invasive Bacterial Infections Surveillance Network. Invasive Haemophilus influenzae in Europe, 2002. www.euibis.org/documents/2002_hibreport.pdf (accessed 7 Jul 2004).
18. Glode MP, Halsey NA, Murray M, Ballard TL, Barenkamp S. Epiglottitis in adults: association with Haemophilus influenzae type b colonization and disease in children. Pediatr Infect Dis 1984; 3: 548–51.
19. Leino T, Auranen K, Makela PH, Kayhty H, Takala AK. Dynamics of natural immunity caused by subclinical infections, case study on Haemophilus influenzae type b (Hib). Epidemiol Infect 2000; 125: 583–91.
20. Added protection planned against Hib. Booster vaccine to be offered following increase in cases. Press release 2003/0071. London: Department of Health, 18 February 2003.
21. Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 2003; 326: 365–6.
22. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New Engl J Med 2003; 348: 1737–46.